Emily L. Ryon
- Co-authors
- Michael A. EvansDavid McNeillChad M. ThorsonJoshua P. KronenfeldNeha GoelNipun B. MerchantBrent A. WillobeeAnn Y. Lee
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (9 papers)Liver Disease Diagnosis and Treatment (6 papers)Economic and Financial Impacts of Cancer (5 papers)
- Journals
- Journal of the American College of SurgeonsAnnals of Surgical OncologyBreast Cancer Research and Treatment
- Partner nations
- United States
In The Last Decade
Emily L. Ryon
23 papers receiving 224 citations
Peers
Comparison fields: 5 of 75
- Surgery 64
- Oncology 60
- Hepatology 39
- Epidemiology 35
- Pulmonary and Respiratory Medicine 33
Countries citing papers authored by Emily L. Ryon
This map shows the geographic impact of Emily L. Ryon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily L. Ryon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily L. Ryon more than expected).
Fields of papers citing papers by Emily L. Ryon
This network shows the impact of papers produced by Emily L. Ryon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily L. Ryon. The network helps show where Emily L. Ryon may publish in the future.
Co-authorship network of co-authors of Emily L. Ryon
This figure shows the co-authorship network connecting the top 25 collaborators of Emily L. Ryon. A scholar is included among the top collaborators of Emily L. Ryon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily L. Ryon. Emily L. Ryon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 3 | |
| 3 | 14 | |
| 4 | 7 | |
| 5 | 12 | |
| 6 | 9 | |
| 7 | 7 | |
| 8 | 1 | |
| 9 | 10 | |
| 10 | 7 | |
| 11 | 4 | |
| 12 | 3 | |
| 13 | 8 | |
| 14 | 5 | |
| 15 | 12 | |
| 16 | 9 | |
| 17 | 12 | |
| 18 | 11 | |
| 19 | 0 | |
| 20 | 3 |
About Emily L. Ryon
Emily L. Ryon is a scholar working on Hepatology, Critical Care and Intensive Care Medicine and Internal Medicine, having authored 26 papers that have together received 227 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Liver Disease Diagnosis and Treatment (6 papers) and Economic and Financial Impacts of Cancer (5 papers). The work is most often cited by research in Hepatology (39 citations), Internal Medicine (12 citations) and Developmental and Educational Psychology (30 citations). Emily L. Ryon has collaborated with scholars based in United States. Frequent co-authors include Michael A. Evans, David McNeill, Chad M. Thorson, Joshua P. Kronenfeld, Neha Goel, Nipun B. Merchant, Brent A. Willobee, Ann Y. Lee, Rachel Lee and Eric J. Silberfein. Their work appears in journals such as Journal of the American College of Surgeons, Annals of Surgical Oncology and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.